Provepharm, a leading international pharmaceutical company specializing in medical colorants and antidotes, today announces the official launch of its new dedicated subsidiary in the United Kingdom. This is an important step in Provepharm’s strategy to establish a direct sales channel in the main European markets, capitalizing on the successful experience in France and the United States.
With the creation of ‘Provepharm UK’, the company aims to strengthen the distribution of its range of stains and antidotes for endoscopy and surgery, providing direct access to healthcare professionals and its customers. Provepharm products had already been available for several years in the United Kingdom via a distributor. With the launch of its British subsidiary, the company confirms its commitment to perpetuate its relationships with healthcare professionals, to follow their evolving needs and to optimize the use of its products, all for the benefit of patients.
“We are very proud of the launch of our subsidiary in the United Kingdom. This will allow us to continue to develop our attractiveness in the market with our holistic approach. Indeed, we provide high quality products, but also a wide range of learning tools to ensure that our customers get the most out of our colorants,” says Michel Feraud, President and CEO of Provepharm. “This initiative aims to strengthen the distribution of our range of dyes and antidotes for endoscopy and surgery in the United Kingdom. Our goal is to confirm Provepharm’s place as a trusted partner and expert in the medical colorants and antidotes markets. »
Provepharm’s UK subsidiary has a dedicated sales team, which will enable the company to provide tailored customer support and improve accessibility to its products. The team is fully committed and trained to respond to requests for products already in the catalog. She will also be able to provide expertise on future products that will arise from Provepharm’s R&D initiatives and business development opportunities.
“I am delighted with the opportunities offered by the British subsidiary in terms of developing the Provepharm portfolio. I look forward to building strong relationships with healthcare professionals, and ensuring that Provepharm UK is recognized as a trusted partner,” says Tim Whelan, Country Director and Head of Provepharm UK Operations.
This article is originally published on mypharma-editions.com
